Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$6.96B |
| 2 |
Salesforce
CRM
|
+$2.62B |
| 3 |
UnitedHealth
UNH
|
+$2.16B |
| 4 |
Meta Platforms (Facebook)
META
|
+$2.12B |
| 5 |
Boeing
BA
|
+$1.8B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$8.99B |
| 2 |
GE Aerospace
GE
|
+$5.58B |
| 3 |
Abbott
ABT
|
+$2.84B |
| 4 |
Micron Technology
MU
|
+$1.85B |
| 5 |
Canadian Natural Resources
CNQ
|
+$1.73B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.1% |
| 2 | Healthcare | 15.12% |
| 3 | Industrials | 12.22% |
| 4 | Consumer Discretionary | 11.82% |
| 5 | Communication Services | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Suncor Energy
SU
$74.7B
| $185M | 0.04% |
4,862,930
-66
| -0% | -$2.55K |
|
227
Pegasystems
PEGA
$5.15B
| $184M | 0.04% |
6,093,292
-1,112,420
| -15% | -$33.3M |
|
228
Weatherford International
WFRD
$6.65B
| $184M | 0.04% |
1,499,093
-2,941,083
| -66% | -$351M |
|
229
Crown Castle
CCI
$31.5B
| $182M | 0.04% |
1,864,932
-583,159
| -24% | -$57.4M |
|
230
Xcel Energy
XEL
$49.1B
| $181M | 0.04% |
3,381,741
+1,131
| +0% | +$61.5K |
|
231
Credo Technology Group
CRDO
$50B
| $176M | 0.04% |
5,525,539
| – | – |
|
232
HDFC Bank
HDB
$119B
| $173M | 0.04% |
5,371,082
-803,546
| -13% | -$23.5M |
|
233
Takeda Pharmaceutical
TAK
$55.6B
| $170M | 0.04% |
13,126,608
+4,678
| +0% | +$61.9K |
|
234
Yum! Brands
YUM
$41B
| $168M | 0.04% |
1,271,219
+350,256
| +38% | +$48.2M |
|
235
Nutanix
NTNX
$17.5B
| $168M | 0.04% |
+2,949,840
| New | +$181M |
|
236
Unity
U
$19.6B
| $167M | 0.04% |
10,272,384
+1,747,936
| +21% | +$37.4M |
|
237
Johnson & Johnson
JNJ
$629B
| $167M | 0.04% |
1,141,138
+505,000
| +79% | +$75.1M |
|
238
PAR Technology
PAR
$741M
| $166M | 0.04% |
3,530,843
| – | – |
|
239
Cognex
CGNX
$10.2B
| $166M | 0.04% |
3,554,442
+1,378
| +0% | +$60.6K |
|
240
Denali Therapeutics
DNLI
$4.04B
| $165M | 0.04% |
7,126,533
+1,076,576
| +18% | +$20.7M |
|
241
Materion
MTRN
$5.9B
| $160M | 0.04% |
1,480,847
+144,149
| +11% | +$16.6M |
|
|
SKX
242
DELISTED
Skechers
SKX
| $159M | 0.03% |
2,300,000
| – | – |
|
243
American Express
AXP
$232B
| $159M | 0.03% |
+686,044
| New | +$159M |
|
244
Snowflake
SNOW
$115B
| $158M | 0.03% |
1,170,441
-1,310,303
| -53% | -$194M |
|
|
LGF.B
245
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $158M | 0.03% |
18,411,237
-2,574,544
| -12% | -$23.1M |
|
|
CFLT
246
DELISTED
Confluent
CFLT
| $153M | 0.03% |
5,187,939
-310,712
| -6% | -$8.93M |
|
247
HubSpot
HUBS
$10.5B
| $152M | 0.03% |
258,423
-193,787
| -43% | -$119M |
|
248
MACOM Technology Solutions
MTSI
$23.7B
| $148M | 0.03% |
1,330,000
| – | – |
|
249
Silicon Laboratories
SLAB
$7.3B
| $145M | 0.03% |
1,306,937
+88,998
| +7% | +$11M |
|
250
Vale
VALE
$61.4B
| $139M | 0.03% |
12,484,413
-3,957,082
| -24% | -$47.6M |
|
Similar funds
Capital Research Global Investors's Q2 2024 Portfolio in Review
As of Q2 2024, Capital Research Global Investors held 450 positions worth $456B, up 3.1% from $442B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Capital Research Global Investors's Q2 2024 filing shows 40 new, 179 increased, 147 reduced and 36 closed positions. Its largest new stake was Oracle: 11,571,987 shares worth $1.63B. The largest sale was Broadcom, an estimated $8.99B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.
- Capital Research Global Investors's largest Q2 2024 buy was Oracle: 11,571,987 shares worth $1.63B.
- Capital Research Global Investors added most to Apple in Q2 2024, an estimated $6.96B increase.
- Capital Research Global Investors's biggest Q2 2024 reduction was Broadcom, cutting an estimated $8.99B.
- Capital Research Global Investors fully exited Norwegian Cruise Line in Q2 2024, selling an estimated $1.19B.
- Capital Research Global Investors's ten largest holdings make up 34% of its $456B portfolio in Q2 2024.
- Capital Research Global Investors opened 40 new positions and closed 36 in Q2 2024.
- Capital Research Global Investors's portfolio value rose 3.1% quarter-over-quarter to $456B.
Based on Capital Research Global Investors's 13F filing for Q2 2024, filed 13 Aug 2024.